Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Sema4 Holdings Corp (NQ: SMFR ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Jan 9, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Sema4 Holdings Corp < Previous 1 2 Next > Sema4 Holdings Corp. (NASDAQ: SMFR) Long Term Shareholder Notice: Investigation of Potential Wrongdoing February 08, 2023 San Diego, CA -- (SBWIRE) -- 02/08/2023 -- An investigation was announced for current long-term investors in shares of Sema4 Holdings Corp. (NASDAQ: SMFR) concerning potential breaches of fiduciary... Via SBWire Sema4 Announces Name Change to GeneDx and Provides Preliminary 2022 Financial Results and 2023 Guidance January 09, 2023 From GeneDx Holdings Corp. Via GlobeNewswire Sema4|GeneDx to Participate in the 41st Annual J.P. Morgan Healthcare Conference December 30, 2022 Sema4|GeneDx President & Chief Executive Officer, Katherine Stueland, to deliver presentation From Sema4 Via GlobeNewswire New Research from Sema4|GeneDx Highlights the Importance of Rapid Exome Sequencing for Diagnosing Mitochondrial Diseases in the NICU December 05, 2022 Data underscores the value of mitochondrial DNA testing and the opportunity to improve health outcomes for critically ill newborns with early medical intervention From Sema4 Via GlobeNewswire Sema4 Reports Third Quarter 2022 Financial Results and New Strategic Direction November 14, 2022 From Sema4 Via GlobeNewswire NASDAQ:SMFR Investor Alert: Deadline on November 7, 2022 in Lawsuit Against Sema4 Holdings Corp. November 09, 2022 San Diego, CA -- (SBWIRE) -- 11/09/2022 -- The Shareholders Foundation announced that a deadline is coming up on November 7, 2022 in the lawsuit filed for certain investors of Sema4 Holdings Corp.... Via SBWire Deadline Alert: Sema4 Holdings Corp. (SMFR, SMFRW) Class Action - Bronstein, Gewirtz & Grossman, LLC, A Prominent Firm, Encourages Shareholders of Last Few Hours to Actively Participate November 07, 2022 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire SMFR FINAL DEADLINE TODAY: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Sema4 Holdings Corp. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - SMFR, SMFRW November 07, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bed Bath & Beyond, Sema4, Medtronic, and Palantir and Encourages Investors to Contact the Firm November 06, 2022 From Bragar Eagel & Squire Via GlobeNewswire SMFR FINAL DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages Sema4 Holdings Corp. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - SMFR, SMFRW November 06, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal SEMA4 HOLDINGS 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Sema4 Holdings Corp. - SMFR November 04, 2022 From Kahn Swick & Foti, LLC Via Business Wire Sema4 to Report Third Quarter 2022 Financial Results on Monday, November 14th, 2022 November 04, 2022 From Sema4 Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Kohl’s, Bed Bath & Beyond, Sema4, and Medtronic and Encourages Investors to Contact the Firm October 31, 2022 From Bragar Eagel & Squire Via GlobeNewswire Sema4|GeneDx Commends New Evidence-Based Guidelines from the National Society of Genetic Counselors Recommending Exome Sequencing as a First-Tier Genetic Test for Unexplained Epilepsies October 31, 2022 Guideline adoption can help end the diagnostic odyssey experienced by many families From Sema4 Via GlobeNewswire ROSEN, A TOP RANKED FIRM, Encourages Sema4 Holdings Corp. Investors With Losses Over $100K to Secure Counsel Before Important November 7 Deadline in Securities Class Action - SMFR, SMFRW October 29, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal Sema4|GeneDx Announces Results from Phase 1 of SeqFirst Study, Demonstrating Broad Utility of Rapid Whole Genome Sequencing for Critically Ill Newborns October 27, 2022 From Sema4 Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Kohl’s, Bed Bath & Beyond, Sema4, and Medtronic and Encourages Investors to Contact the Firm October 26, 2022 From Bragar Eagel & Squire Via GlobeNewswire Sema4|GeneDx collaborates on new research demonstrating genome and exome sequencing deliver more diagnostic certainty than multi-gene panels October 26, 2022 Exome and genome tests report 30% fewer inconclusive results and a higher diagnostic yield compared to multi-gene panel tests; research to be presented at American Society of Human Genetics Annual... From Sema4 Via GlobeNewswire ROSEN, NATIONAL TRIAL LAWYERS, Encourages Sema4 Holdings Corp. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - SMFR, SMFRW October 22, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against TuSimple, Kohl’s, Bed Bath & Beyond, and Sema4 and Encourages Investors to Contact the Firm October 21, 2022 From Bragar Eagel & Squire Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sema4, Medtronic, Palantir, and Fulgent and Encourages Investors to Contact the Firm October 16, 2022 From Bragar Eagel & Squire Via GlobeNewswire ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Sema4 Holdings Corp. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SMFR, SMFRW October 16, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal Study Demonstrates the Utility of Exome Sequencing for Diagnosing Autism Spectrum Disorders October 13, 2022 From Sema4 Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sema4, Medtronic, Palantir, and Fulgent and Encourages Investors to Contact the Firm October 11, 2022 From Bragar Eagel & Squire Via GlobeNewswire Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Sema4 Holdings Corp. (SMFR; SMFRW) Investors and Encourages Investors to Contact the Firm Before November 7, 2022 October 07, 2022 From Kirby McInerney LLP Via Business Wire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sema4, Medtronic, Palantir, and Fulgent and Encourages Investors to Contact the Firm October 06, 2022 From Bragar Eagel & Squire Via GlobeNewswire Sema4|GeneDx To Provide Whole Genome Sequencing and Interpretation Services for Landmark Genomic Newborn Screening Study October 05, 2022 The largest study of its kind in North America, GUARDIAN is expected to improve population health by identifying more than 250 preventable and treatable conditions, many of which are not covered today... From Sema4 Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sema4, Medtronic, Palantir, and Fulgent and Encourages Investors to Contact the Firm October 02, 2022 From Bragar Eagel & Squire Via GlobeNewswire ROSEN, A LEADING LAW FIRM, Encourages Sema4 Holdings Corp. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SMFR, SMFRW October 02, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal INVESTOR NOTICE: Sema4 Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - SMFR; SMFRW September 20, 2022 From Robbins Geller Rudman & Dowd LLP Via Business Wire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.